I-mab Biopharma Us Limited
Clinical trials sponsored by I-mab Biopharma Us Limited, explained in plain language.
-
New drug combo aims to fight tough stomach and esophageal cancers
Disease control Recruiting nowThis study tests whether adding the experimental drug givastomig to standard immunotherapy and chemotherapy helps people with advanced stomach or esophageal cancer live longer without their cancer growing. About 180 adults whose tumors have certain proteins (CLDN18.2 and PD-L1) w…
Phase: PHASE2 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control
Last updated May 17, 2026 00:41 UTC
-
New hope for advanced cancer: experimental drug enters human testing
Disease control Recruiting nowThis early-stage study tests an experimental drug called TJ033721 (givastomig) in people with advanced or metastatic solid tumors, including stomach, pancreatic, and bile duct cancers. The main goals are to check the drug's safety, find the best dose, and see how the body process…
Phase: PHASE1 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control
Last updated May 13, 2026 16:03 UTC